Biome Australia Limited (BIO.AX)
ASX · AUD · Consumer Defensive · Packaged Foods
A$0.365 (+1.39%) as of
Key statistics
- Market cap
- 84.46M
- P/E (TTM)
- 18.25
- Forward P/E
- 15.21
- EPS (TTM)
- 0.0200
- Dividend yield
- 0.00%
- 52-week range
- 0.2000 – 0.4900
- Beta
- 0.96
- Revenue (TTM)
- 23.88M
- Profit margin
- 15.11%
- Analyst target
- A$0.75
- Volume
- 126.08k
About Biome Australia Limited
Biome Australia Limited engages in the development, commercialization, and marketing of live biotherapeutics and complementary medicines in Australia and internationally. It provides its products under the Activated Probiotics and Activated Therapeutics brand names. The company's products are used to support the management of low mood and sleep, bone health, iron malabsorption, mild eczema, and IBS. It markets its products through community pharmacies, independent health practitioners, and health professionals. The company was incorporated in 2018 and is based in Collingwood, Australia.
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Headquarters
- Collingwood, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.